Shareholders Equity: The sum of preferred and common equity items.
Moleculin Biotech, Inc. (MBRX) had Shareholders Equity of $5.98M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-21.76M |
|
-- |
|
-- |
|
$26.64M |
|
$-26.64M |
|
$4.88M |
|
$-21.76M |
|
$-21.76M |
|
$-21.76M |
|
$-21.76M |
|
$-21.76M |
|
$-21.76M |
|
$-26.64M |
|
$-26.52M |
|
0.14M |
|
0.14M |
|
$-158.00 |
|
$-158.00 |
|
| Balance Sheet Financials | |
$5.19M |
|
$0.16M |
|
$11.73M |
|
$16.93M |
|
$5.36M |
|
-- |
|
$5.59M |
|
$10.95M |
|
$5.98M |
|
$-5.17M |
|
|
Shareholders Equity |
$5.98M |
0.14M |
|
| Cash Flow Statement Financials | |
$-23.86M |
|
$-0.01M |
|
$4.63M |
|
$23.55M |
|
$4.28M |
|
$-19.27M |
|
$1.73M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.97 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-23.88M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-363.99% |
|
421.03% |
|
-128.58% |
|
-363.99% |
|
$44.24 |
|
$-173.36 |
|
$-173.26 |
|